Earnings release · JNJ
Johnson & Johnson reports Q3 2026 results, raises 2026 guidance
Johnson & Johnson · Filed · SEC Form 8-K, Item 2.02
Revenue
$25.4 billion
+5.9% vs a year ago
EPS
$0.09
not detected
Guidance
raisedoutlook statement
Automated extract. The items below were picked out of the company's press release by software and may be wrong or incomplete.
Please read the original before relying on any figure. Not investment advice.
Why it matters
Revenue climbed 5.9% year on year to $25.4 billion, and EPS was $0.09. The company lifted its guidance, which is usually read as management's view of coming periods improving.
Written automatically by Stocknote's note engine from the figures on this page and the company's previous release. Every number in this note is checked against those figures. Not investment advice.
What the company states
Revenue
$25.4 billion +5.9% vs a year ago
…2026 Third-Quarter reported sales growth of 5.9% to $25.4 Billion with operational growth of 6.0%* a…
EPS
$0.09
…2026 Third-Quarter earnings per share (EPS) of $0.09 reflects a one-time special charge for the proposed talc litigation resolution, the acquisit…
Guidance
Guidance raised
…Johnson & Johnson reports Q3 2026 results, raises 2026 guidance…
Disclaimer: This page is generated automatically from public SEC filings for information only. Stocknote does not edit the company's release and does not guarantee the accuracy of the extracted items. Read the full disclaimer here.